The Division of Clinical Pharmacology at the University of Utah is devoted to help further understanding of the use of medications in special populations including children and pregnant women. Established in 1999 as the Pediatric Pharmacology Program by Dr. Robert Ward has been very successful in beginning to bridge the gap between what is known and what needs to be known. Today, with the recruitment of Dr. Michael Spigarelli, it has expanded to a more broad focus, bringing research experience, study design expertise and computer modeling to further the mission.
To date, only 20 - 30% of drugs used to treat children have been studied in children in any manner and even a smaller number have been tested in pregnant women. The Division of Clinical Pharmacology at the University of Utah is working to eliminate this deficiency in accordance with FDA regulations, and in response to the stimulus from the Best Pharmaceuticals for Children's Act, the Pediatric Research Equity Act (Renewed as the Food and Drug Administration Amendments Act (FDAAA)) as well as the European Medicines Agency (EMEA) which requires drug studies for children during the drug development and approval process.
The Division of Clinical Pharmacology has studied numerous children and therapeutic agents since its creation. The program is located within the University of Utah's Department of Pediatrics and the Woman and Child Institute. We work in conjunction with the University Hospital, Primary Children's Medical Center, Intermountain Medical Center, and the faculty of the University of Utah.